312 related articles for article (PubMed ID: 35705944)
1. Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.
Sutter MB; Watson H; Yonke N; Weitzen S; Leeman L
BMC Pediatr; 2022 Jun; 22(1):345. PubMed ID: 35705944
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy.
Morrison TM; MacMillan KDL; Melvin P; Singh R; Murzycki J; Van Vleet MW; Rothstein R; O'Shea TF; Gupta M; Schiff DM; Wachman EM
Hosp Pediatr; 2022 May; 12(5):530-538. PubMed ID: 35403199
[TBL] [Abstract][Full Text] [Related]
4. Opioid treatment for opioid withdrawal in newborn infants.
Zankl A; Martin J; Davey JG; Osborn DA
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.
Lee JJ; Chen J; Eisler L; Li G; Davis JM; Sun LS
J Perinatol; 2019 Nov; 39(11):1535-1545. PubMed ID: 31316147
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
7. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
[TBL] [Abstract][Full Text] [Related]
8. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
[TBL] [Abstract][Full Text] [Related]
10. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
[TBL] [Abstract][Full Text] [Related]
11. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
[TBL] [Abstract][Full Text] [Related]
12. Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
Devlin LA; Hu Z; Merhar SL; Ounpraseuth ST; Simon AE; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Fung CM; Wright T; Ross J; McAllister JM; Crowley M; Shaikh SK; Christ L; Brown J; Riccio J; Wong Ramsey K; Braswell EF; Tucker L; McAlmon K; Dummula K; Weiner J; White JR; Newman S; Snowden JN; Young LW;
JAMA Pediatr; 2024 Jun; 178(6):525-532. PubMed ID: 38619854
[TBL] [Abstract][Full Text] [Related]
13. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization and convalescent care cost in neonatal opioid withdrawal syndrome.
Ronan K; Hughes Driscoll CA; Decker E; Gopalakrishnan M; El Metwally D
J Neonatal Perinatal Med; 2023; 16(1):49-57. PubMed ID: 36530095
[TBL] [Abstract][Full Text] [Related]
15. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
[TBL] [Abstract][Full Text] [Related]
16. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
Brown MS; Hayes MJ; Thornton LM
J Perinatol; 2015 Apr; 35(4):278-83. PubMed ID: 25357093
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
[TBL] [Abstract][Full Text] [Related]
18. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
[TBL] [Abstract][Full Text] [Related]
19. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
[TBL] [Abstract][Full Text] [Related]
20. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]